Rheumatology
| Gout
Rheumatology
Gout

Is colchicine prophylaxis required with start-low go-slow allopurinol dose escalation in gout? A non-inferiority randomised double-blind placebo-controlled trial

book_2 Source: Ann Rheum Dis. 2023;82(12):1626-1634.
calendar_today Published on Medfyle: December 2023
import_contacts 7 min
headphones 6 min

In this medfyle

Gout is very common, and although there are urate-lowering therapies available, many people experience flares when they first go on treatment. New strategies explore anti-inflammatory prophylaxis, and dose-escalation protocols.

Expert commentary

Johannes Bijlsma, MD, PhD

Emeritus Professor of Rheumatology, Utrecht University, The Netherlands.
Past associate editor ARD (2000-2018) and Past President of EULAR (2017-2019).

About this Medfyle
Read more arrow_downward Hide arrow_upward

©2023 Medfyle. All rights reserved.

Stamp L, Horne A, Mihov B, Drake J, Haslett J, Chapman PT, Frampton C, Dalbeth N. Is colchicine prophylaxis required with start-low go-slow allopurinol dose escalation in gout? A non-inferiority randomised double-blind placebo-controlled trial. Ann Rheum Dis. 2023 Dec;82(12):1626-1634. doi: 10.1136/ard-2023-224731. Epub 2023 Aug 31. PMID: 37652661.

The authors of the original article and the publisher were not involved in the creation of the summary.


Feedback